Arcturus Therapeutics Files Form 20-F

SAN DIEGO, May 14, 2018 (GLOBE NEWSWIRE) — Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company, today announced the filing of the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2017 with the U.S. Securities and...